SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
QALYs: Some Challenges
15 references·16 citing·36 second hop
QALYs: Some Challenges (2009)QALYs: Some ChallengesQALYs: The Basics (2009)QALYs: The BasicsThe Expected Utility Model: Its Variants, Purposes, Evidence and Limitations (2007)The Expected Utility Model: I…Interpretations of Utility and Their Implications for the Valuation of Health (2007)Interpretations of Utility an…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…QALY maximisation and people's preferences: a methodological review of the literature (2004)QALY maximisation and people'…Incorporating societal concerns for fairness in numerical valuations of health programmes (1999)Incorporating societal concer…Cost-Value Analysis in Health Care (1999)Cost-Value Analysis in Health…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …The Person-trade-off Approach to Valuing Health Care Programs (1995)The Person-trade-off Approach…Maximizing health benefits vs egalitarianism: An Australian survey of health issues (1995)Maximizing health benefits vs…The trade-off between severity of illness and treatment effect in cost-value analysis of health care (1993)The trade-off between severit…Prospect theory: An analysis of decision under risk (1988)Prospect theory: An analysis …QALYfying the value of life. (1987)QALYfying the value of life.Prospect Theory: An Analysis of Decision under Risk (1979)Prospect Theory: An Analysis …A BEHAVIORAL MODEL OF RATIONAL CHOICE (1955)A BEHAVIORAL MODEL OF RATIONA…How to Value Orphan Drugs? A Review of European Value Assessment Frameworks (2021)How to Value Orphan Drugs? A …Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation (2019)Estimating Quality of Life De…The Use of MCDA in HTA: Great Potential, but More Effort Needed (2017)The Use of MCDA in HTA: Great…Patient and general public preferences for health states: A call to reconsider current guidelines (2016)Patient and general public pr…Markov Models and Cost Effectiveness Analysis: Applications in Medical Research (2016)Markov Models and Cost Effect…A new proposal for priority setting in Norway: Open and fair (2016)A new proposal for priority s…Cost–effectiveness thresholds in the USA: are they coming? Are they already here? (2015)Cost–effectiveness thresholds…Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis (2014)Guidance on priority setting …Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt (2013)Recommendations for Reporting…Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? (2013)Estimating the willingness to…Disability weights for suicidal thoughts and non-fatal suicide attempts (2011)Disability weights for suicid…Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada (2011)Bridging health technology as…An Equity Framework for Health Technology Assessments (2011)An Equity Framework for Healt…The efficiency frontier approach to economic evaluation of health‐care interventions (2010)The efficiency frontier appro…Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients (2010)Combining multicriteria decis…Toward a Consensus on the QALY (2009)Toward a Consensus on the QALYThe Framing of Decisions and the Psychology of Choice (1981)The precaution adoption process. (1988)The magical number seven, plus or minus two: Some limits on our capacity for processing information. (1994)Not just for the money: an economic theory of personal motivation (1997)Contemporary Guidance for Stated Preference Studies (2017)Theory of games and economic behavior (2019)Well-being : the foundations of hedonic psychology (1999)How Can Measures of Subjective Well-Being Be Used to Inform Public Policy? (2007)Outcomes of social care for adults: developing a preference-weighted measure. (2012)Does gratitude enhance prosociality?: A meta-analytic review. (2017)Taking Rights Seriously (1978)Economics of coronary artery bypass grafting. (1985)Methods for the analysis of quality-of-life and survival data in health technology assessment. (1999)The value of DALY life: problems with ethics and validity of disability adjusted life years (1999)A utility maximization model for evaluation of health care programs. (1972)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Making Descriptive Use of Prospect Theory to Improve the Prescriptive Use of Expected Utility (2001)Conceptualizing a Model (2012)Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Assetization (2020)Intergenerational Equity: An Exploration of the ‘Fair Innings’ Argument (1997)Understanding DALYs (1997)Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project (2010)Pricing and reimbursement of orphan drugs: the need for more transparency (2011)Multiple Criteria Decision Analysis for Health Technology Assessment (2012)Risk, Ambiguity, and the Savage Axioms (1961)Judgment under Uncertainty: Heuristics and Biases (1975)Exploration and Exploitation in Organizational Learning (1991)Explicating dynamic capabilities: the nature and microfoundations of (sustainable) enterprise performance (2007)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Theory of the firm: Managerial behavior, agency costs and ownership structure (1976)Advances in prospect theory: Cumulative representation of uncertainty (1992)
this work references cited by second hop

References

  • 1979Prospect Theory: An Analysis of Decision under Risk48,459 cited
  • 1988Prospect theory: An analysis of decision under risk32,475 cited
  • 1955A BEHAVIORAL MODEL OF RATIONAL CHOICE15,851 cited
  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2007The Expected Utility Model: Its Variants, Purposes, Evidence and Limitations1,428 cited
  • 2009QALYs: The Basics757 cited
  • 1987QALYfying the value of life.456 cited
  • 2007Interpretations of Utility and Their Implications for the Valuation of Health449 cited
  • 2004QALY maximisation and people's preferences: a methodological review of the literature431 cited
  • 1999Incorporating societal concerns for fairness in numerical valuations of health programmes407 cited
  • 1995The Person-trade-off Approach to Valuing Health Care Programs288 cited
  • 1999Cost-Value Analysis in Health Care272 cited
  • 1995Maximizing health benefits vs egalitarianism: An Australian survey of health issues263 cited
  • 1993The trade-off between severity of illness and treatment effect in cost-value analysis of health care198 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cited by

  • 2014Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis183 cited
  • 2016Patient and general public preferences for health states: A call to reconsider current guidelines162 cited
  • 2009Toward a Consensus on the QALY140 cited
  • 2016A new proposal for priority setting in Norway: Open and fair137 cited
  • 2011Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada126 cited
  • 2010The efficiency frontier approach to economic evaluation of health‐care interventions119 cited
  • 2017The Use of MCDA in HTA: Great Potential, but More Effort Needed114 cited
  • 2010Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients105 cited
  • 2013Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?91 cited
  • 2019Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation81 cited
  • 2011An Equity Framework for Health Technology Assessments79 cited
  • 2015Cost–effectiveness thresholds in the USA: are they coming? Are they already here?76 cited
  • 2013Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt73 cited
  • 2016Markov Models and Cost Effectiveness Analysis: Applications in Medical Research67 cited
  • 2011Disability weights for suicidal thoughts and non-fatal suicide attempts65 cited
  • 2021How to Value Orphan Drugs? A Review of European Value Assessment Frameworks62 cited